An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors

NCT05481502 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
160
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris